Enzymatic DNA Synthesis Market Size, Share & Trends Analysis Report By Service (Oligonucleotide Synthesis, Gene Synthesis), By Application (Synthetic Biology, Genetic Engineering, Vaccine Development, Others), By End Use (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 28, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. Enzymatic DNA Synthesis Market, By Service 2022-2034 (USD MILLION/ Units)
    1. Oligonucleotide Synthesis
    2. Gene Synthesis
  2. Enzymatic DNA Synthesis Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Synthetic Biology
    2. Genetic Engineering
    3. Vaccine Development
    4. Others
  3. Enzymatic DNA Synthesis Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Biopharmaceutical Companies
    2. Academic & Research Institutes
    3. Contract Research Organizations
  4. Regional Enzymatic DNA Synthesis Market
    1. North America
      1. North America Enzymatic DNA Synthesis Market By Service 2022-2034 (USD MILLION/ Units)
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
      2. North America Enzymatic DNA Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Synthetic Biology
        2. Genetic Engineering
        3. Vaccine Development
        4. Others
      3. North America Enzymatic DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Academic & Research Institutes
        3. Contract Research Organizations
      4. U.S.
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      5. Canada
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
    2. Europe
      1. Europe Enzymatic DNA Synthesis Market By Service 2022-2034 (USD MILLION/ Units)
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
      2. Europe Enzymatic DNA Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Synthetic Biology
        2. Genetic Engineering
        3. Vaccine Development
        4. Others
      3. Europe Enzymatic DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Academic & Research Institutes
        3. Contract Research Organizations
      4. U.K.
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      5. Germany
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      6. France
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      7. Spain
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      8. Italy
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      9. Russia
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      10. Nordic
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      11. Benelux
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      12. Rest of Europe
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
    3. APAC
      1. APAC Enzymatic DNA Synthesis Market By Service 2022-2034 (USD MILLION/ Units)
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
      2. APAC Enzymatic DNA Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Synthetic Biology
        2. Genetic Engineering
        3. Vaccine Development
        4. Others
      3. APAC Enzymatic DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Academic & Research Institutes
        3. Contract Research Organizations
      4. China
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      5. Korea
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      6. Japan
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      7. India
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      8. Australia
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      9. Taiwan
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      10. South East Asia
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      11. Rest of Asia-Pacific
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
    4. Middle East and Africa
      1. Middle East and Africa Enzymatic DNA Synthesis Market By Service 2022-2034 (USD MILLION/ Units)
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
      2. Middle East and Africa Enzymatic DNA Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Synthetic Biology
        2. Genetic Engineering
        3. Vaccine Development
        4. Others
      3. Middle East and Africa Enzymatic DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Academic & Research Institutes
        3. Contract Research Organizations
      4. UAE
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      5. Turkey
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      6. Saudi Arabia
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      7. South Africa
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      8. Egypt
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      9. Nigeria
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      10. Rest of MEA
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
    5. LATAM
      1. LATAM Enzymatic DNA Synthesis Market By Service 2022-2034 (USD MILLION/ Units)
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
      2. LATAM Enzymatic DNA Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Synthetic Biology
        2. Genetic Engineering
        3. Vaccine Development
        4. Others
      3. LATAM Enzymatic DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Academic & Research Institutes
        3. Contract Research Organizations
      4. Brazil
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      5. Mexico
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      6. Argentina
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      7. Chile
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      8. Colombia
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations
      9. Rest of LATAM
        1. Oligonucleotide Synthesis
        2. Gene Synthesis
        3. Synthetic Biology
        4. Genetic Engineering
        5. Vaccine Development
        6. Others
        7. Biopharmaceutical Companies
        8. Academic & Research Institutes
        9. Contract Research Organizations

We are featured on: